IOVA

IOVANCE BIOTHERAPEUTICS INC

Healthcare | Mid Cap

-$0.26

EPS Forecast

$74.19

Revenue Forecast

Announcing earnings for the quarter ending 2024-12-31 soon
REPLReplimune Group IncKODKodiak Sciences IncCRSPCrispr Therapeutics AgDNLIDenali Therapeutics IncHALOHalozyme Therapeutics IncNVAXNovavax IncMRNAModerna Inc